Guerbet LLC

 Guerbet LLC, the U.S. subsidiary, was established in January of 2002.

Currently, Guerbet LLC is responsible for the marketing, sales, and distribution of the first macrocyclic and ionic gadolinium-based contrast in the USA, Dotarem® (gadoterate meglumine) Injection, and the only oil-based based contrast agent currently available in the USA, Lipiodol® (ethiodized oil) Injection.

Guerbet LLC headquarters is located in Princeton, NJ.

Dotarem® Full Prescribing Information Read more
Lipiodol® Full Prescribing Information Read more